Upcoming Ask the Expert Webinar – The Asp-PSC Trial: What Patients Need to Know
Register for our first live Ask the Expert of 2026, taking place on Monday 2nd March at 7pm (UK).
Read MoreWorld CCA Day: Tackling Cholangiocarcinoma
How is PSC Support tackling bile duct cancer? Discover the research we’re funding to improve early detection and treatment for cholangiocarcinoma (CCA).
Read MoreProgress and Plans at the ERN RARE-LIVER Members’ Meeting 2026
Martine Walmsley shares project updates and future goals from the 2026 Prague members’ meeting.
Read MoreImproving Liver Care for People with PSC
Medway NHS Foundation Trust becomes the 20th UK service to achieve IQILS accreditation.
Read MoreLeadership Update
New PSC Support leadership announced
Read MoreEpstein-Barr Virus and PSC
New research explores a potential link between Epstein-Barr virus and primary sclerosing cholangitis.
Read MoreMajor Milestone Reached in PSC Cancer Risk Study
100 samples collected: DNA methylation study advances early cancer detection in PSC.
Read MoreJanuary 2026 Research Roundup
PSC Support recently attended the British Association for the Study of the Liver (BASL) Immune Special Interest Group (SIG) meeting. This meeting highlighted important progress in research and care, and on new medications for autoimmune liver diseases.
Read MoreProgress Update: Characterising Genetic Changes in Bile Ducts
PSC research on genetic changes in bile ducts is now in its key analytical phase to unlock understanding.
Read MoreMolecular Signatures Identified to Predict Primary Sclerosing Cholangitis Progression and Cancer Risk
New blood-based markers could help predict primary sclerosing cholangitis progression and cancer risk.
Read More